Research / ITP / Fundamental state Inspectable configuration
State dimensions Filing 0001213900-22-012344 General Corporate
Debt relative to revenue 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
6.10% · OPTIONAL · VALID
Capex intensity 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
15.58% · OPTIONAL · VALID
Operating cash generation 30th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1.51% · OPTIONAL · VALID
Revenue growth 84th Own-history percentile · N=19
Evidence method Yoy · gp.fundamentals.revenue
59.38% · CORE · VALID
Inventory pressure 15th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
3.63% · OPTIONAL · VALID
Gross margin 40th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.gross_margin
6.85% · CORE · VALID
Operating margin 55th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
0.91% · CORE · VALID
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
0.06% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 40 states Self-history eligible
Dec 31, 2020 7/9 normalized Amended as filed Mar 31, 2021 7/7 normalized Level 3 Jun 30, 2021 7/7 normalized Level 3 Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/8 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/9 normalized Level 3 Mar 31, 2023 8/8 normalized Level 3 Jun 30, 2023 8/8 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 6/7 normalized Level 3 Mar 31, 2024 6/6 normalized Level 3 Jun 30, 2024 6/6 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 8/8 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/7 normalized Level 3 Sep 30, 2025 7/7 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 21.41%
Current 6.10%
Delta -15.31% Capex Intensity Decreased
Previous 27.97%
Current 15.58%
Delta -12.38% Cash Generation Decreased
Previous 20.24%
Current -1.51%
Delta -21.76% Growth Increased
Previous 35.17%
Current 59.38%
Delta 24.21% Inventory Pressure Decreased
Previous 16.90%
Current 3.63%
Delta -13.27% Margin Increased
Previous 4.04%
Current 6.85%
Delta 2.81% Profitability Increased
Previous -0.44%
Current 0.91%
Delta 1.35% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.